Skip to main content
The Brazilian Journal of Infectious Diseases logoLink to The Brazilian Journal of Infectious Diseases
editorial
. 2023 Jun 27;27(4):102787. doi: 10.1016/j.bjid.2023.102787

Brazil needs to be vaccinated

Leonardo Weissmann a,b,, Rosana Richtmann a,c
PMCID: PMC10336399  PMID: 37391175

The Brazilian National Immunization Program (NIP), coordinated by the Ministry of Health in cooperation with the state and municipal health departments, was created in 1973 and strengthened by the successful campaign of Smallpox Eradication campaign. The program has made many achievements in its history, which are attributed to the fact that the NIP follows the doctrinal principles of the Unified Health System: universality, equity of assistance, and organizational principle of decentralization. The Brazilian NIP was successful based on effective communication campaigns. Another positive aspect of achieving the goal of high vaccination coverage in Brazil during the last few years has been having national laboratories that produce vaccines of excellent effectiveness, quality, and competence, making the national program more accessible and cost effective. This represents an efficient public policy that has a significant impact on the morbidity and mortality profiles of the Brazilian population, adapting to changes in the country's political, epidemiological, and social fields. In this context, the country registered the elimination of poliomyelitis, as well as the elimination of rubella and congenital rubella syndrome, and neonatal tetanus. In addition, thousands of Brazilians have stopped getting sick from vaccine-preventable diseases because of immunization actions.1,2

In recent years, the NIP has been facing a critical challenge: the reduction in the achievement of the recommended targets for vaccination coverage rates, mainly from 2016 (Table 1), and aggravated by the COVID-19 pandemic, a period in which there was a gradual decline from 10% to 20%.3, 4, 5 In September 2022, The Pan American Health Organization (PAHO) stated that Brazil, the Dominican Republic, Haiti, and Peru are at very high risk for the reintroduction of poliomyelitis, as dwindling vaccination rates during the coronavirus pandemic have led to historic lows in protection against the disease.6 Correspondingly, reduced vaccination rates leave the country susceptible to other preventable diseases, such as measles, meningitis, and invasive pneumococcal diseases.4

Table 1.

Vaccination Coverage (%). Brazil, 2013 to 2022.

Vaccine 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Bacille Calmette-Guérin (BCG) 107 107 105 96 98 100 87 77 75 90
Hepatitis B <30 days of life NA 89 91 82 86 88 79 66 67 83
Rotavirus 94 93 95 89 85 91 85 78 72 77
Meningococcal C 100 96 98 92 87 88 87 79 72 79
Pentavalent (Diphtheria-Tetanus-Pertussis ‒ DTP/ hepatitis B/ Haemophilus influenzae type b) 96 95 96 89 84 88 71 78 72 77
Pneumococcal 94 93 94 95 92 95 89 82 75 82
Polio (3rd dose < 1 years old) 101 97 98 84 85 90 84 77 71 77
Yellow fever 51 47 46 45 47 60 62 58 58 61
Hepatitis A 0 60 97 72 79 83 85 76 68 73
Pneumococcal (1st ref) 93 88 88 84 76 82 83 72 66 72
Meningococcal C (1st ref) 92 89 88 94 79 80 86 77 69 75
Triple viral – measles/mumps/rubella (1st dose) 107 113 96 95 86 93 93 81 75 81
Triple viral (2nd dose) 69 93 80 77 73 77 82 64 53 58
Varicella NA NA NA NA NA NA NA 74 67 73
DTP (3rd dose) 98 95 97 90 NA NA NA NA 72 77

NA, not available.

Source: National Immunization Program Information System (updated on 05/26/2023).3

Some factors can explain this situation.

A study aimed at evaluating the spatial dynamics of the vaccination coverage rate of children <1 year old by a municipality in Northeast Brazil in 2016 and 2017 demonstrated the existence of geographic areas and clusters with low rates.7 Another study showed low vaccination coverage associated with socioeconomic inequalities that still prevail in the Brazilian Amazon, such as poverty (aOR = 2.12, 95% CI 1.06–4.21), low maternal schooling (aOR = 2.60, 95% CI 1.28–5.29), and time of residence of the child in the urban area of the city (aOR = 0.73, 95% CI 0.55–0.95).8

One of the main concerns in the country is vaccination hesitation, which is old in Europe and the United States and is growing increasingly. Vaccination hesitation is defined as a “delay in accepting or refusing recommended vaccines despite their availability in health services”.9 During the COVID-19 pandemic, we lived with a veritable epidemic of deliberate or accidental misinformation, which contributed significantly to increasing the risk of infection and promoting distrust in vaccines. Fake vaccine news is a crucial target of the anti-vaccine movements, making the hyperconnected Brazilian population an easy prey. The most susceptible digital Brazilians failed to recognize the logical differences between fake and accurate news.10

The data presented show that several actions are necessary for the country to regain its prominent position in decades, with high vaccination coverage. First, having a plan for activities directed toward each region according to its needs is fundamental. Second, we need to clarify that the lack of risk perception of infectious diseases does not mean the absence of risk of reintroduction of vaccine-preventable diseases. Third, the population needs correct information emphasizing the benefits, efficacy, and safety of immunizers to dispel fear of adverse effects and regain confidence in vaccines. Before everything is too late, BRAZIL NEEDS TO BE VACCINATED!

Conflicts of interest

The authors declare no conflicts of interest.

References

  • 1.Domingues CMAS, Maranhão AGK, Teixeira AM, Fantinato FFS, Domingues RAS. 46 anos do programa nacional de imunizações: uma história repleta de conquistas e desafios a serem superados. Cad Saude Pub. 2020;36(Suppl 2) doi: 10.1590/0102-311X00222919. [DOI] [PubMed] [Google Scholar]
  • 2.Temporão JG. O programa nacional de imunizações (PNI): origens e desenvolvimento. Hist Cienc Saude Manguinhos. 2003;10(Suppl 2):601–617. [PubMed] [Google Scholar]
  • 3.Sistema De informações do programa nacional de imunizações. Brasília: SIPNI [cited 2023 May 26]. Available from: http://sipni.datasus.gov.br/si-pni-web/.
  • 4.Pan American Health Organization. As COVID-19 continues to impact the Americas, dwindling vaccination rates leave countries susceptible to polio and other preventable diseases. [cited 2023 May 18]. Available from: https://www.paho.org/en/news/21-9-2022-covid-19-continues-impact-americas-dwindling-vaccination-rates-leave-countries.
  • 5.Silveira MM, Conrad NL, Leivas Leite FP. Effect of COVID-19 on vaccination coverage in Brazil. J Med Microbiol. 2021;70(11) doi: 10.1099/jmm.0.001466. [DOI] [PubMed] [Google Scholar]
  • 6.Pan American Health Organization. 14th meeting of the regional certification commission for the polio endgame in the region of the Americas – meeting report. [cited 2023 May 18]. Available from: https://www.paho.org/en/file/115436/download?token=F2Mh0ez6.
  • 7.Cunha NSP, Fahrat SCL, de Olinda RA, et al. Spatial analysis of vaccine coverage on the first year of life in the northeast of Brazil. BMC Public Health. 2022;22:1204. doi: 10.1186/s12889-022-13589-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Branco FL, Pereira TM, Delfino BM, et al. Socioeconomic inequalities are still a barrier to full child vaccine coverage in the Brazilian Amazon: a cross-sectional study in Assis Brasil, Acre, Brazil. Int J Equity Health. 2014;13:118. doi: 10.1186/s12939-014-0118-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev Saude Publ. 2018;52:96. doi: 10.11606/S1518-8787.2018052001199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Galhardi CP, Freire NP, Fagundes MCM, Minayo MC de S, Cunha ICKO. Fake news e hesitação vacinal no contexto da pandemia da COVID-19 no Brasil. Ciênc Saúde Colet. 2022;27:1849–1858. doi: 10.1590/1413-81232022275.24092021. [DOI] [PubMed] [Google Scholar]

Articles from The Brazilian Journal of Infectious Diseases are provided here courtesy of Elsevier

RESOURCES